Related Experiment Video
Updated: Jun 15, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
Long-acting depot formulations of naltrexone for heroin dependence: a review
Evgeny M Krupitsky1, Elena A Blokhina
1Laboratory of Clinical Psychopharmacology of Addictions, Valdman Institute of Pharmacology, St Petersburg State Pavlov Medical University, St Petersburg, Russia. kru@ek3506.spb.edu
Purpose Of Review:
The major problem with the oral formulation of naltrexone for heroin dependence is poor compliance (adherence). Long-acting sustained release formulations of naltrexone (implantable and injectable) might help to improve compliance and, thus, increase the efficacy of abstinence-oriented treatment of heroin dependence with naltrexone.
Recent Findings:
There have been several implantable and injectable formulations of naltrexone developed within the last decade. It was demonstrated that some of them are effective and relatively well tolerated medications for relapse prevention in heroin addicts. However, advantages and disadvantages of these new medications have never been systematically analyzed.
Summary:
Long-acting sustained release formulations of naltrexone are well tolerated and more effective for relapse prevention in heroin addicts than the oral ones.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Oral Drug Delivery Systems: Continuous-Release Systems
Drug Dependence
Modified-Release Drug Delivery Systems: Overview
Analgesia and Pain Management
Modified-Release Drug Delivery Systems: Drug Release Characteristics

